Clinical Perspectives and Novel Preclinical Models of Malignant Pleural Mesothelioma: A Critical Review

A Ebrahimi, G Ak, C Özel, H İzgördü… - ACS Pharmacology & …, 2024 - ACS Publications
Pleural mesothelioma (PM), a rare malignant tumor explicitly associated with asbestos and
erionite exposures, has become a global health problem due to limited treatment options …

[HTML][HTML] Scalable production and in vitro efficacy of inhaled erlotinib nanoemulsion for enhanced efficacy in non-small cell lung cancer (NSCLC)

G Chauhan, X Wang, C Yousry, V Gupta - Pharmaceutics, 2023 - mdpi.com
Non-small cell lung cancer (NSCLC) is a global concern as one of the leading causes of
cancer deaths. The treatment options for NSCLC are limited to systemic chemotherapy …

Surface-Modified Inhaled Microparticle-Encapsulated Celastrol for Enhanced Efficacy in Malignant Pleural Mesothelioma

X Wang, G Chauhan, ARL Tacderas, A Muth… - International Journal of …, 2023 - mdpi.com
Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer affecting the pleural
lining of the lungs. Celastrol (Cela), a pentacyclic triterpenoid, has demonstrated promising …